Exclusive weekly insights for sharemarket success.
Tim Lincoln, Co-Founder and Chief Investment Officer, and Matt Swartz, Senior Portfolio Manager, will join the conversation once a month to share their passion and strategy for Lincoln Indicator’s Managed Funds, as well as their insights for investors.
Join Kien Trinh, Head of Research, and Jason Yin, Senior Equities Analyst, as they dissect the week’s reporting season results. Dive into China’s economic concerns, the US interest rate implications, and the ripple effects on global markets.
The pair explore the performance of Star Stocks like GUD Holdings (GUD), Cochlear (COH), Computershare (CPU), and CSL Limited (CSL). Unravel the intricacies behind Challenger Group (CGF)’s numbers and weigh the benefits of share buybacks versus dividends.
We hope you enjoy the episode.
Experience Stock Doctor yourself by taking a FREE trial today.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.